ChoA Pharmaceutical Co.Ltd (034940) — Cash Flow-to-Debt Ratio
ChoA Pharmaceutical Co.Ltd (034940) has a Cash Flow-to-Debt Ratio of -0.01x as of June 2026, meaning its operating cash flow of ₩-505.40 Million could theoretically repay 0% of its total liabilities (₩41.51 Billion) in one year. See ChoA Pharmaceutical Co.Ltd financial flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ChoA Pharmaceutical Co.Ltd Cash Flow-to-Debt Ratio (2004–2025)
Historical debt coverage capacity for ChoA Pharmaceutical Co.Ltd across 14 annual periods. For the full cash flow conversion analysis, see how efficiently does ChoA Pharmaceutical Co.Ltd generate cash.
Annual Cash Flow-to-Debt Ratio for ChoA Pharmaceutical Co.Ltd (2004–2025)
Year-by-year debt coverage analysis for ChoA Pharmaceutical Co.Ltd. Check ChoA Pharmaceutical Co.Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (KRW) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.10x | ₩-4.18 Billion | ₩42.92 Billion | ▲ +12.9% |
| 2024 | -0.11x | ₩-4.47 Billion | ₩39.94 Billion | ▼ -168.9% |
| 2023 | -0.04x | ₩-1.48 Billion | ₩35.46 Billion | ▲ +5.5% |
| 2022 | -0.04x | ₩-1.44 Billion | ₩32.80 Billion | ▲ +9.1% |
| 2021 | -0.05x | ₩-1.48 Billion | ₩30.59 Billion | ▼ -160.6% |
| 2020 | 0.08x | ₩1.92 Billion | ₩24.07 Billion | ▼ -35.3% |
| 2019 | 0.12x | ₩4.16 Billion | ₩33.69 Billion | ▲ +81.5% |
| 2018 | 0.07x | ₩2.04 Billion | ₩30.08 Billion | ▲ +395.3% |
| 2017 | -0.02x | ₩-675.51 Million | ₩29.34 Billion | ▼ -167.4% |
| 2016 | 0.03x | ₩930.42 Million | ₩27.26 Billion | ▼ -21.8% |
| 2015 | 0.04x | ₩1.19 Billion | ₩27.19 Billion | ▲ +95.1% |
| 2014 | 0.02x | ₩625.52 Million | ₩27.96 Billion | ▼ -87.2% |
| 2013 | 0.17x | ₩3.53 Billion | ₩20.19 Billion | ▲ +6.6% |
| 2004 | 0.16x | ₩3.57 Billion | ₩21.78 Billion | — |